Agah Ramtin

Chief Medical Officer

Agah Ramtin has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jan 22, 2026.

On the most recent filing, Agah Ramtin is listed as Chief Medical Officer at RenovoRx, Inc. Inside the rolling window, Agah Ramtin reported 7 open-market purchases totaling $56K in RNXT and no open-market sales. The largest disclosed transaction in the window is a purchase of 12,000 RNXT shares on Dec 16, 2025, worth $10K.

Companies traded

Other insiders at RNXT

Insider Buying

$56K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RNXTPurchase$10KJan 22SEC ↗
RNXTPurchase$8KJan 5SEC ↗
RNXTPurchase$169Jan 2SEC ↗
RNXTPurchase$10KDec 17SEC ↗
RNXTPurchase$10KDec 8SEC ↗
RNXTPurchase$8KNov 24SEC ↗
RNXTPurchase$10KNov 24SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Agah Ramtin made?

Agah Ramtin has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.

Which companies does Agah Ramtin trade?

Agah Ramtin has filed SEC Form 4 disclosures for 1 company, including RNXT.

When was Agah Ramtin's most recent SEC Form 4 filing?

Agah Ramtin's most recent SEC Form 4 filing on Tracefour is dated Jan 22, 2026.

What is Agah Ramtin's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Agah Ramtin is listed as Chief Medical Officer.

What is Agah Ramtin's total buy and sell value in the current window?

Inside the rolling retention window, Agah Ramtin bought $56K and sold $0 based on SEC Form 4 filings.

What was Agah Ramtin's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 12,000 RNXT shares on 2025-12-16, worth $10K, per SEC Form 4 filings.